SCHEMBL10044121

SCHEMBL10044121

CCCC(=O)NNC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL23529597 0.97
SCHEMBL6634673 0.85 HDAC3 (0.63)
SCHEMBL11027904 0.84
SCHEMBL11029486 0.82 HSP90AA1 (0.58)
SCHEMBL29040279 0.80 HSP90AA1 (0.61)
SCHEMBL24658011 0.80 HSP90AA1 (0.61)
SCHEMBL13568685 0.80 HSP90AA1 (0.61)
SCHEMBL24657787 0.80 HSP90AA1 (0.61)
SCHEMBL6124941 0.80 KDM4E (0.64)
SCHEMBL20392386 0.79 CTSD (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106279167-B Matrine compound derivative and preparation method and application thereof 中国医学科学院医药生物技术研究所 2018-11-13 CN claimed
EP-3057948-A1 SELECTIVELY SUBSTITUTED QUINOLINE COMPOUNDS Eisai R&D Management Co., Ltd. (JP) 2016-08-24 EP claimed
WO-2015057655-A1 SELECTIVELY SUBSTITUTED QUINOLINE COMPOUNDS EISAI R&D MANAGEMENT CO., LTD. (JP) 2015-04-23 WO claimed
WO-2024149345-A1 LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME PROFOUNDBIO US CO. (US) 2024-07-18 WO disclosed
EP-4366777-A2 LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME PROFOUNDBIO US CO. (US) 2024-05-15 EP disclosed
WO-2023223055-A1 ANTI-VIRAL COMPOUNDS Infex Therapeutics Limited (GB) 2023-11-23 WO disclosed
WO-2023280227-A2 LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME PROFOUNDBIO US CO. (US) 2023-01-12 WO disclosed
EP-3873938-A1 DC-SIGN ANTIBODY CONJUGATES COMPRISING STING AGONISTS Novartis AG (CH) 2021-09-08 EP disclosed
EP-3313884-B1 ANTI-CD123 ANTIBODIES AND CONJUGATES AND DERIVATIVES THEREOF IMMUNOGEN INC (US) 2020-11-18 EP disclosed
EP-3737665-A1 PRODRUGS OF KETAMINE, COMPOSITIONS AND USES THEREOF XW Laboratories Inc. (KY) 2020-11-18 EP disclosed
CN-110062753-A Antiviral compounds 哈普洛根有限责任公司 2019-07-26 CN disclosed
US-20170158598-A1 PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO DOW AGROSCIENCES LLC (US) 2017-06-08 US disclosed
US-9629363-B2 Pesticidal compositions and processes related thereto DOW AGROSCIENCES LLC (US) 2017-04-25 US disclosed
US-20160037779-A1 PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO DOW AGROSCIENCES LLC (US) 2016-02-11 US disclosed
US-9211281-B2 Pesticidal compositions and processes related thereto DOW AGROSCIENCES LLC (US) 2015-12-15 US disclosed
US-20140171311-A1 PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO DOW AGROSCIENCES LLC (US) 2014-06-19 US disclosed
US-20130041178-A1 METHOD FOR PREPARING OPTICALLY ACTIVE N-METHYLAMINO ACIDS AND OPTICALLY ACTIVE N-METHYLAMINO ACID AMIDES MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2013-02-14 US disclosed
WO-2012017971-A1 PEST CONTROL COMPOSITION 住友化学株式会社 (JP) 2012-02-09 WO disclosed
US-7919623-B2 Naphthyridine derivatives having inhibitory activity against HIV integrase SHIONOGI & CO., LTD. (JP) 2011-04-05 US disclosed
US-20090227621-A1 Naphthyridine derivatives having inhibitory activity against hiv integrase SHIONOGI & CO., LTD. (JP) 2009-09-10 US disclosed